Dublin, Oct. 09, 2020 (GLOBE NEWSWIRE) -- The "Influenza Diagnostics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Global Influenza Diagnostics Market to Reach $3.6 Billion by 2027
Amid the COVID-19 crisis, the global market for Influenza Diagnostics estimated at US$2.5 Billion in the year 2020, is projected to reach a revised size of US$3.6 Billion by 2027, growing at a CAGR of 5.3% over the analysis period 2020-2027.
RIDT, one of the segments analyzed in the report, is projected to record a 5.8% CAGR and reach US$2.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the RT-PCR segment is readjusted to a revised 5% CAGR for the next 7-year period.
The U. S. Market is Estimated at $685 Million, While China is Forecast to Grow at 8% CAGR
The Influenza Diagnostics market in the U. S. is estimated at US$685 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$755.1 Million by the year 2027 trailing a CAGR of 8.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.9% and 4.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.
Cell Culture Segment to Record 4.6% CAGR
In the global Cell Culture segment, USA, Canada, Japan, China and Europe will drive the 4.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$245.6 Million in the year 2020 will reach a projected size of US$326.7 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$484 Million by the year 2027, while Latin America will expand at a 5.6% CAGR through the analysis period.
The report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Competitors identified in this market include, among others:
Analytik Jena AG
Becton, Dickinson and Company
F. Hoffmann-La Roche AG
Meridian Bioscience, Inc.
SA Scientific, Ltd.
Thermo Fisher Scientific, Inc.
Key Topics Covered:
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Global Competitor Market Shares
Influenza Diagnostics Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Influenza Diagnostics Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
Influenza Diagnostics Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019
Influenza Diagnostics Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
RIDT (Test Type) World Market by Region/Country in US$ Million: 2020 to 2027
RIDT (Test Type) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
RIDT (Test Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
RT-PCR (Test Type) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
RT-PCR (Test Type) Historic Market Perspective by Region/Country in US$ Million: 2012 to 2019
RT-PCR (Test Type) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027
Cell Culture (Test Type) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027
Cell Culture (Test Type) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to 2019
Cell Culture (Test Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
Other Test Types (Test Type) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to 2027
Other Test Types (Test Type) Market Historic Review by Region/Country in US$ Million: 2012 to 2019
Other Test Types (Test Type) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
Hospitals (End-Use) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2020-2027
Hospitals (End-Use) Global Historic Analysis in US$ Million by Region/Country: 2012-2019
Hospitals (End-Use) Distribution of Global Sales by Region/Country: 2012 VS 2020 VS 2027
POCT (End-Use) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2020 through 2027
POCT (End-Use) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2012 to 2019
POCT (End-Use) Global Market Share Distribution by Region/Country for 2012, 2020, and 2027
Laboratories (End-Use) Global Opportunity Assessment in US$ Million by Region/Country: 2020-2027
Laboratories (End-Use) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019
Laboratories (End-Use) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS 2027
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
Market Facts & Figures
Influenza Diagnostics Market Share (in %) by Company: 2019 & 2025
Influenza Diagnostics Market Estimates and Projections in US$ Million by Test Type: 2020 to 2027
Influenza Diagnostics Market by Test Type: A Historic Review in US$ Million for 2012-2019
Influenza Diagnostics Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
Influenza Diagnostics Latent Demand Forecasts in US$ Million by End-Use: 2020 to 2027
Influenza Diagnostics Historic Demand Patterns by End-Use in US$ Million for 2012-2019
Influenza Diagnostics Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027
Total Companies Profiled: 38
For more information about this report visit https://www.researchandmarkets.com/r/vmdj3b
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900